Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-05-08 @ 9:51 AM
Study NCT ID:
NCT00038805
Status:
TERMINATED
Last Update Posted:
2018-10-31
First Post:
2002-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | High Risk Acute Myeloid Leukemia | View |
| None | Acute Lymphocytic Leukemia | View |
| None | Chronic Myeloid Leukemia | View |
| None | Myelodysplastic Syndrome | View |
| None | ALL | View |
| None | AML | View |
| None | MDS | View |
| None | CML | View |
| None | CMML | View |
| None | Nonmyeloablative Preparative Regimen | View |
| None | Mylotarg | View |
| None | CMA-676 | View |